- Conditions
- AMN, AMN Gene Mutation, X-ALD
- Interventions
- SBT101, Imitation Procedure
- Genetic · Procedure
- Lead sponsor
- SwanBio Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years · Male only
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
Source: ClinicalTrials.gov public record
Updated Oct 30, 2025 · Synced May 21, 2026, 9:45 PM EDT